FVAL: A High-Tech Value Play With Risky Downside Exposure
Fidelity Value Factor ETF (FVAL) has a 0.15% expense ratio. It outperforms its peers, but faces higher risk. Read an ...
Upstart: Great Q4 But Pricey, Given Model Uncertainties And High Take Rates
Upstart's AI-driven platform aims to revolutionize credit assessments. Learn more about its potential and the risks tied to ...
Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...